Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anal Cancer Stage III A”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Not applicableStudy completedNCT05130073
What this trial is testing

4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer

Who this might be right for
Anal Squamous Cell CarcinomaStage 0 Anal Cancer AJCC v8Stage I Anal Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 41
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Large-scale testing (Phase 3)Study completedNCT01651949
What this trial is testing

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

Who this might be right for
Genital WartsAnal CancerAnal Intraepithelial Neoplasia
Merck Sharp & Dohme LLC 2,520
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Ended earlyNCT01324141
What this trial is testing

Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer

Who this might be right for
Anal Cancer
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Study completedNCT03690921
What this trial is testing

Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial

Who this might be right for
Anal Canal Squamous Cell CarcinomaStage I Anal Cancer AJCC v8Stage II Anal Cancer AJCC v8+6 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Testing effectiveness (Phase 2)Study completedNCT00093379
What this trial is testing

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

Who this might be right for
Anal Cancer
M.D. Anderson Cancer Center 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06465914
What this trial is testing

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

Who this might be right for
Genital WartPenile CancerAnal Cancer+7 more
Shanghai Bovax Biotechnology Co., Ltd. 9,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04230759
What this trial is testing

Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

Who this might be right for
Anal CancerAnal CarcinomaAnal Cancer Stage III+1 more
Goethe University 180
Large-scale testing (Phase 3)Active Not RecruitingNCT04444921
What this trial is testing

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaMetastatic Anal Squamous Cell Carcinoma+4 more
National Cancer Institute (NCI) 205
Large-scale testing (Phase 3)Study completedNCT00075868
What this trial is testing

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Who this might be right for
Anal CancerColorectal CancerDrug/Agent Toxicity by Tissue/Organ+1 more
Radiation Therapy Oncology Group 233